Boothbay Fund Management, LLC Zoetis Inc. Transaction History

Boothbay Fund Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$145.54 - $178.83 $369,526 - $454,049	2,539 New	2,539 $440,000
Q4 2022 Feb 14, 2023	BUY	$131.14 - $157.47 $222,151 - $266,754	1,694 New	1,694 $248,000
Q1 2021 May 17, 2021	SELL	$144.0 - $169.39 $187,200 - $220,206	-1,300 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$157.07 - $174.35 $204,191 - $226,655	1,300 New	1,300 $215,000
Q2 2019 Aug 14, 2019	SELL	$97.98 - $114.28 $203,210 - $237,016	-2,074 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$81.56 - $100.67 $44,368 - $54,764	-544 Reduced 20.78%	2,074 $209,000
Q4 2018 Feb 14, 2019	BUY	$79.28 - $95.27 $207,555 - $249,416	2,618 New	2,618 $224,000
Q4 2017 Feb 14, 2018	SELL	$63.24 - $72.8 $219,189 - $252,324	-3,466 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$59.73 - $65.4 $207,024 - $226,676	3,466	3,466 $221,000

1,948

408M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $78B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.